Sam Brusco, Associate Editor03.03.23
Medical robotics company Noah Medical has achieved U.S. Food and Drug Administration (FDA) clearance for its Galaxy System to provide bronchoscopic visualization of and access to patient airways in diagnostic and therapeutic procedures.
The Galaxy System’s advanced imaging tech offers real-time location updates and is engineered to improve tool-in-lesion and diagnostic yield.
“While various technologies to diagnose lung cancer have been utilized over time, the diagnostic yield has remained relatively low,” Jian Zhang, Ph.D., Noah Medical founder and CEO told the press. “The Galaxy System is designed to close this gap in the market, giving clinicians a safe and easy-to-use platform to potentially improve diagnostic yield and produce better clinical outcomes. With this FDA clearance, we are excited to move into the commercial phase of our journey.”
The Galaxy System’s TiLT Technology features integrated tomosynthesis and augmented fluoroscopy. An always-on-camera bronchoscope enables direct visualization for the whole procedure, including at the time of biopsy. Four-way bronchoscope articulation helps navigate peripheral lesions.
According to the company, Galaxy is the only robotic, navigated bronchoscopy system with a single-use, disposable bronchoscope intentionally designed to boost efficiency and workflow, as well as reduce risk of cross-contamination.
The Galaxy System’s advanced imaging tech offers real-time location updates and is engineered to improve tool-in-lesion and diagnostic yield.
“While various technologies to diagnose lung cancer have been utilized over time, the diagnostic yield has remained relatively low,” Jian Zhang, Ph.D., Noah Medical founder and CEO told the press. “The Galaxy System is designed to close this gap in the market, giving clinicians a safe and easy-to-use platform to potentially improve diagnostic yield and produce better clinical outcomes. With this FDA clearance, we are excited to move into the commercial phase of our journey.”
The Galaxy System’s TiLT Technology features integrated tomosynthesis and augmented fluoroscopy. An always-on-camera bronchoscope enables direct visualization for the whole procedure, including at the time of biopsy. Four-way bronchoscope articulation helps navigate peripheral lesions.
According to the company, Galaxy is the only robotic, navigated bronchoscopy system with a single-use, disposable bronchoscope intentionally designed to boost efficiency and workflow, as well as reduce risk of cross-contamination.